1. Home
  2. NBY vs HELP Comparison

NBY vs HELP Comparison

Compare NBY & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.47

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$7.63

Market Cap

366.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBY
HELP
Founded
2000
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
366.7M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
NBY
HELP
Price
$1.47
$7.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
591.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.42
N/A
EPS
0.76
N/A
Revenue
$370,000.00
N/A
Revenue This Year
$23.91
N/A
Revenue Next Year
$32.05
N/A
P/E Ratio
$1.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$5.76
52 Week High
$19.95
$8.23

Technical Indicators

Market Signals
Indicator
NBY
HELP
Relative Strength Index (RSI) 43.82 58.71
Support Level $0.94 $7.33
Resistance Level $2.66 $8.23
Average True Range (ATR) 0.24 0.62
MACD 0.30 0.16
Stochastic Oscillator 43.78 89.74

Price Performance

Historical Comparison
NBY
HELP

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: